Our mission and purpose is to accelerate medical research on brain repair with patients in mind.
Our neuroscientists conduct basic, translational and clinical research to develop novel therapeutic interventions and improve the lives of patients suffering from neurological disorders, in particular Parkinson’s disease and brain injuries.
- PNI has pioneer expertise, dating back to the 90s, in neural stem cell-based therapies for the treatment of neurological disorders within an industry setting at Layton Biosciences, where the world’s first cryopreserved neural product was developed and manufactured under current Good Manufacturing Practices and transplanted into patients afflicted with stroke.
- Unique expertise in stem cell biology and translational research expanded through partnerships with academic and industry experiences to advance preclinical development which is so critical for the successful translation of promising technologies to improve human lives.
